The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artificial Blood Cells Market Research Report 2025
Synopsis
Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
The global Artificial Blood Cells market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Artificial Blood Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Blood Cells.
Report Scope
The Artificial Blood Cells market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Blood Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Blood Cells manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech
Segment by Type
Animal Hemoglobin
Human Hemoglobin
Stem Cell
Others
Segment by Application
Cardiovascular Diseases
Anemia
Organ Transplant
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Blood Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Blood Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Artificial blood cell is a product made to act as a substitute for red blood cells. While true blood serves many different functions, artificial blood is designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
The global Artificial Blood Cells market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Artificial Blood Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Blood Cells.
Report Scope
The Artificial Blood Cells market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Blood Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Blood Cells manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech
Segment by Type
Animal Hemoglobin
Human Hemoglobin
Stem Cell
Others
Segment by Application
Cardiovascular Diseases
Anemia
Organ Transplant
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Blood Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Blood Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Artificial Blood Cells Market Overview
1.1 Product Overview and Scope of Artificial Blood Cells
1.2 Artificial Blood Cells Segment by Type
1.2.1 Global Artificial Blood Cells Market Value Comparison by Type (2024-2030)
1.2.2 Animal Hemoglobin
1.2.3 Human Hemoglobin
1.2.4 Stem Cell
1.2.5 Others
1.3 Artificial Blood Cells Segment by Application
1.3.1 Global Artificial Blood Cells Market Value by Application: (2024-2030)
1.3.2 Cardiovascular Diseases
1.3.3 Anemia
1.3.4 Organ Transplant
1.3.5 Others
1.4 Global Artificial Blood Cells Market Size Estimates and Forecasts
1.4.1 Global Artificial Blood Cells Revenue 2019-2030
1.4.2 Global Artificial Blood Cells Sales 2019-2030
1.4.3 Global Artificial Blood Cells Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Artificial Blood Cells Market Competition by Manufacturers
2.1 Global Artificial Blood Cells Sales Market Share by Manufacturers (2019-2024)
2.2 Global Artificial Blood Cells Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Artificial Blood Cells Average Price by Manufacturers (2019-2024)
2.4 Global Artificial Blood Cells Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artificial Blood Cells, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artificial Blood Cells, Product Type & Application
2.7 Artificial Blood Cells Market Competitive Situation and Trends
2.7.1 Artificial Blood Cells Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Artificial Blood Cells Players Market Share by Revenue
2.7.3 Global Artificial Blood Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Blood Cells Retrospective Market Scenario by Region
3.1 Global Artificial Blood Cells Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Artificial Blood Cells Global Artificial Blood Cells Sales by Region: 2019-2030
3.2.1 Global Artificial Blood Cells Sales by Region: 2019-2024
3.2.2 Global Artificial Blood Cells Sales by Region: 2025-2030
3.3 Global Artificial Blood Cells Global Artificial Blood Cells Revenue by Region: 2019-2030
3.3.1 Global Artificial Blood Cells Revenue by Region: 2019-2024
3.3.2 Global Artificial Blood Cells Revenue by Region: 2025-2030
3.4 North America Artificial Blood Cells Market Facts & Figures by Country
3.4.1 North America Artificial Blood Cells Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Artificial Blood Cells Sales by Country (2019-2030)
3.4.3 North America Artificial Blood Cells Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Artificial Blood Cells Market Facts & Figures by Country
3.5.1 Europe Artificial Blood Cells Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Artificial Blood Cells Sales by Country (2019-2030)
3.5.3 Europe Artificial Blood Cells Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Blood Cells Market Facts & Figures by Country
3.6.1 Asia Pacific Artificial Blood Cells Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Artificial Blood Cells Sales by Country (2019-2030)
3.6.3 Asia Pacific Artificial Blood Cells Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Artificial Blood Cells Market Facts & Figures by Country
3.7.1 Latin America Artificial Blood Cells Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Artificial Blood Cells Sales by Country (2019-2030)
3.7.3 Latin America Artificial Blood Cells Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Blood Cells Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Blood Cells Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Artificial Blood Cells Sales by Country (2019-2030)
3.8.3 Middle East and Africa Artificial Blood Cells Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Artificial Blood Cells Sales by Type (2019-2030)
4.1.1 Global Artificial Blood Cells Sales by Type (2019-2024)
4.1.2 Global Artificial Blood Cells Sales by Type (2025-2030)
4.1.3 Global Artificial Blood Cells Sales Market Share by Type (2019-2030)
4.2 Global Artificial Blood Cells Revenue by Type (2019-2030)
4.2.1 Global Artificial Blood Cells Revenue by Type (2019-2024)
4.2.2 Global Artificial Blood Cells Revenue by Type (2025-2030)
4.2.3 Global Artificial Blood Cells Revenue Market Share by Type (2019-2030)
4.3 Global Artificial Blood Cells Price by Type (2019-2030)
5 Segment by Application
5.1 Global Artificial Blood Cells Sales by Application (2019-2030)
5.1.1 Global Artificial Blood Cells Sales by Application (2019-2024)
5.1.2 Global Artificial Blood Cells Sales by Application (2025-2030)
5.1.3 Global Artificial Blood Cells Sales Market Share by Application (2019-2030)
5.2 Global Artificial Blood Cells Revenue by Application (2019-2030)
5.2.1 Global Artificial Blood Cells Revenue by Application (2019-2024)
5.2.2 Global Artificial Blood Cells Revenue by Application (2025-2030)
5.2.3 Global Artificial Blood Cells Revenue Market Share by Application (2019-2030)
5.3 Global Artificial Blood Cells Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Dextro-Sang Corporation
6.1.1 Dextro-Sang Corporation Corporation Information
6.1.2 Dextro-Sang Corporation Description and Business Overview
6.1.3 Dextro-Sang Corporation Artificial Blood Cells Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Dextro-Sang Corporation Artificial Blood Cells Product Portfolio
6.1.5 Dextro-Sang Corporation Recent Developments/Updates
6.2 BioPure Corporation
6.2.1 BioPure Corporation Corporation Information
6.2.2 BioPure Corporation Description and Business Overview
6.2.3 BioPure Corporation Artificial Blood Cells Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BioPure Corporation Artificial Blood Cells Product Portfolio
6.2.5 BioPure Corporation Recent Developments/Updates
6.3 Sangart
6.3.1 Sangart Corporation Information
6.3.2 Sangart Description and Business Overview
6.3.3 Sangart Artificial Blood Cells Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sangart Artificial Blood Cells Product Portfolio
6.3.5 Sangart Recent Developments/Updates
6.4 Northfield Laboratories
6.4.1 Northfield Laboratories Corporation Information
6.4.2 Northfield Laboratories Description and Business Overview
6.4.3 Northfield Laboratories Artificial Blood Cells Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Northfield Laboratories Artificial Blood Cells Product Portfolio
6.4.5 Northfield Laboratories Recent Developments/Updates
6.5 Baxter International
6.5.1 Baxter International Corporation Information
6.5.2 Baxter International Description and Business Overview
6.5.3 Baxter International Artificial Blood Cells Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Baxter International Artificial Blood Cells Product Portfolio
6.5.5 Baxter International Recent Developments/Updates
6.6 Dentritech
6.6.1 Dentritech Corporation Information
6.6.2 Dentritech Description and Business Overview
6.6.3 Dentritech Artificial Blood Cells Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dentritech Artificial Blood Cells Product Portfolio
6.6.5 Dentritech Recent Developments/Updates
6.7 FluorO2 Therapeutics
6.6.1 FluorO2 Therapeutics Corporation Information
6.6.2 FluorO2 Therapeutics Description and Business Overview
6.6.3 FluorO2 Therapeutics Artificial Blood Cells Sales, Revenue and Gross Margin (2019-2024)
6.4.4 FluorO2 Therapeutics Artificial Blood Cells Product Portfolio
6.7.5 FluorO2 Therapeutics Recent Developments/Updates
6.8 Nuvox Pharma
6.8.1 Nuvox Pharma Corporation Information
6.8.2 Nuvox Pharma Description and Business Overview
6.8.3 Nuvox Pharma Artificial Blood Cells Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Nuvox Pharma Artificial Blood Cells Product Portfolio
6.8.5 Nuvox Pharma Recent Developments/Updates
6.9 Alpha Therapeutic Corporation
6.9.1 Alpha Therapeutic Corporation Corporation Information
6.9.2 Alpha Therapeutic Corporation Description and Business Overview
6.9.3 Alpha Therapeutic Corporation Artificial Blood Cells Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Alpha Therapeutic Corporation Artificial Blood Cells Product Portfolio
6.9.5 Alpha Therapeutic Corporation Recent Developments/Updates
6.10 HemoBioTech
6.10.1 HemoBioTech Corporation Information
6.10.2 HemoBioTech Description and Business Overview
6.10.3 HemoBioTech Artificial Blood Cells Sales, Revenue and Gross Margin (2019-2024)
6.10.4 HemoBioTech Artificial Blood Cells Product Portfolio
6.10.5 HemoBioTech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Blood Cells Industry Chain Analysis
7.2 Artificial Blood Cells Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Blood Cells Production Mode & Process
7.4 Artificial Blood Cells Sales and Marketing
7.4.1 Artificial Blood Cells Sales Channels
7.4.2 Artificial Blood Cells Distributors
7.5 Artificial Blood Cells Customers
8 Artificial Blood Cells Market Dynamics
8.1 Artificial Blood Cells Industry Trends
8.2 Artificial Blood Cells Market Drivers
8.3 Artificial Blood Cells Market Challenges
8.4 Artificial Blood Cells Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Artificial Blood Cells Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Artificial Blood Cells Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Artificial Blood Cells Market Competitive Situation by Manufacturers in 2023
Table 4. Global Artificial Blood Cells Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Artificial Blood Cells Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Artificial Blood Cells Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Artificial Blood Cells Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Artificial Blood Cells Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Artificial Blood Cells, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Artificial Blood Cells, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Artificial Blood Cells, Product Type & Application
Table 12. Global Key Manufacturers of Artificial Blood Cells, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Artificial Blood Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Blood Cells as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Artificial Blood Cells Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Artificial Blood Cells Sales by Region (2019-2024) & (K Units)
Table 18. Global Artificial Blood Cells Sales Market Share by Region (2019-2024)
Table 19. Global Artificial Blood Cells Sales by Region (2025-2030) & (K Units)
Table 20. Global Artificial Blood Cells Sales Market Share by Region (2025-2030)
Table 21. Global Artificial Blood Cells Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Artificial Blood Cells Revenue Market Share by Region (2019-2024)
Table 23. Global Artificial Blood Cells Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Artificial Blood Cells Revenue Market Share by Region (2025-2030)
Table 25. North America Artificial Blood Cells Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Artificial Blood Cells Sales by Country (2019-2024) & (K Units)
Table 27. North America Artificial Blood Cells Sales by Country (2025-2030) & (K Units)
Table 28. North America Artificial Blood Cells Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Artificial Blood Cells Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Artificial Blood Cells Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Artificial Blood Cells Sales by Country (2019-2024) & (K Units)
Table 32. Europe Artificial Blood Cells Sales by Country (2025-2030) & (K Units)
Table 33. Europe Artificial Blood Cells Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Artificial Blood Cells Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Artificial Blood Cells Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Artificial Blood Cells Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Artificial Blood Cells Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Artificial Blood Cells Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Artificial Blood Cells Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Artificial Blood Cells Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Artificial Blood Cells Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Artificial Blood Cells Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Artificial Blood Cells Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Artificial Blood Cells Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Artificial Blood Cells Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Artificial Blood Cells Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Artificial Blood Cells Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Artificial Blood Cells Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Artificial Blood Cells Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Artificial Blood Cells Sales (K Units) by Type (2019-2024)
Table 51. Global Artificial Blood Cells Sales (K Units) by Type (2025-2030)
Table 52. Global Artificial Blood Cells Sales Market Share by Type (2019-2024)
Table 53. Global Artificial Blood Cells Sales Market Share by Type (2025-2030)
Table 54. Global Artificial Blood Cells Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Artificial Blood Cells Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Artificial Blood Cells Revenue Market Share by Type (2019-2024)
Table 57. Global Artificial Blood Cells Revenue Market Share by Type (2025-2030)
Table 58. Global Artificial Blood Cells Price (US$/Unit) by Type (2019-2024)
Table 59. Global Artificial Blood Cells Price (US$/Unit) by Type (2025-2030)
Table 60. Global Artificial Blood Cells Sales (K Units) by Application (2019-2024)
Table 61. Global Artificial Blood Cells Sales (K Units) by Application (2025-2030)
Table 62. Global Artificial Blood Cells Sales Market Share by Application (2019-2024)
Table 63. Global Artificial Blood Cells Sales Market Share by Application (2025-2030)
Table 64. Global Artificial Blood Cells Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Artificial Blood Cells Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Artificial Blood Cells Revenue Market Share by Application (2019-2024)
Table 67. Global Artificial Blood Cells Revenue Market Share by Application (2025-2030)
Table 68. Global Artificial Blood Cells Price (US$/Unit) by Application (2019-2024)
Table 69. Global Artificial Blood Cells Price (US$/Unit) by Application (2025-2030)
Table 70. Dextro-Sang Corporation Corporation Information
Table 71. Dextro-Sang Corporation Description and Business Overview
Table 72. Dextro-Sang Corporation Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Dextro-Sang Corporation Artificial Blood Cells Product
Table 74. Dextro-Sang Corporation Recent Developments/Updates
Table 75. BioPure Corporation Corporation Information
Table 76. BioPure Corporation Description and Business Overview
Table 77. BioPure Corporation Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. BioPure Corporation Artificial Blood Cells Product
Table 79. BioPure Corporation Recent Developments/Updates
Table 80. Sangart Corporation Information
Table 81. Sangart Description and Business Overview
Table 82. Sangart Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Sangart Artificial Blood Cells Product
Table 84. Sangart Recent Developments/Updates
Table 85. Northfield Laboratories Corporation Information
Table 86. Northfield Laboratories Description and Business Overview
Table 87. Northfield Laboratories Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Northfield Laboratories Artificial Blood Cells Product
Table 89. Northfield Laboratories Recent Developments/Updates
Table 90. Baxter International Corporation Information
Table 91. Baxter International Description and Business Overview
Table 92. Baxter International Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Baxter International Artificial Blood Cells Product
Table 94. Baxter International Recent Developments/Updates
Table 95. Dentritech Corporation Information
Table 96. Dentritech Description and Business Overview
Table 97. Dentritech Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Dentritech Artificial Blood Cells Product
Table 99. Dentritech Recent Developments/Updates
Table 100. FluorO2 Therapeutics Corporation Information
Table 101. FluorO2 Therapeutics Description and Business Overview
Table 102. FluorO2 Therapeutics Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. FluorO2 Therapeutics Artificial Blood Cells Product
Table 104. FluorO2 Therapeutics Recent Developments/Updates
Table 105. Nuvox Pharma Corporation Information
Table 106. Nuvox Pharma Description and Business Overview
Table 107. Nuvox Pharma Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Nuvox Pharma Artificial Blood Cells Product
Table 109. Nuvox Pharma Recent Developments/Updates
Table 110. Alpha Therapeutic Corporation Corporation Information
Table 111. Alpha Therapeutic Corporation Description and Business Overview
Table 112. Alpha Therapeutic Corporation Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Alpha Therapeutic Corporation Artificial Blood Cells Product
Table 114. Alpha Therapeutic Corporation Recent Developments/Updates
Table 115. HemoBioTech Corporation Information
Table 116. HemoBioTech Description and Business Overview
Table 117. HemoBioTech Artificial Blood Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. HemoBioTech Artificial Blood Cells Product
Table 119. HemoBioTech Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Artificial Blood Cells Distributors List
Table 123. Artificial Blood Cells Customers List
Table 124. Artificial Blood Cells Market Trends
Table 125. Artificial Blood Cells Market Drivers
Table 126. Artificial Blood Cells Market Challenges
Table 127. Artificial Blood Cells Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Artificial Blood Cells
Figure 2. Global Artificial Blood Cells Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Artificial Blood Cells Market Share by Type in 2023 & 2030
Figure 4. Animal Hemoglobin Product Picture
Figure 5. Human Hemoglobin Product Picture
Figure 6. Stem Cell Product Picture
Figure 7. Others Product Picture
Figure 8. Global Artificial Blood Cells Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Artificial Blood Cells Market Share by Application in 2023 & 2030
Figure 10. Cardiovascular Diseases
Figure 11. Anemia
Figure 12. Organ Transplant
Figure 13. Others
Figure 14. Global Artificial Blood Cells Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Artificial Blood Cells Market Size (2019-2030) & (US$ Million)
Figure 16. Global Artificial Blood Cells Sales (2019-2030) & (K Units)
Figure 17. Global Artificial Blood Cells Average Price (US$/Unit) & (2019-2030)
Figure 18. Artificial Blood Cells Report Years Considered
Figure 19. Artificial Blood Cells Sales Share by Manufacturers in 2023
Figure 20. Global Artificial Blood Cells Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Artificial Blood Cells Players: Market Share by Revenue in 2023
Figure 22. Artificial Blood Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Artificial Blood Cells Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Artificial Blood Cells Sales Market Share by Country (2019-2030)
Figure 25. North America Artificial Blood Cells Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Artificial Blood Cells Sales Market Share by Country (2019-2030)
Figure 29. Europe Artificial Blood Cells Revenue Market Share by Country (2019-2030)
Figure 30. Germany Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Artificial Blood Cells Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Artificial Blood Cells Revenue Market Share by Region (2019-2030)
Figure 37. China Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Artificial Blood Cells Sales Market Share by Country (2019-2030)
Figure 48. Latin America Artificial Blood Cells Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Artificial Blood Cells Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Artificial Blood Cells Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Artificial Blood Cells Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Artificial Blood Cells by Type (2019-2030)
Figure 58. Global Revenue Market Share of Artificial Blood Cells by Type (2019-2030)
Figure 59. Global Artificial Blood Cells Price (US$/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Artificial Blood Cells by Application (2019-2030)
Figure 61. Global Revenue Market Share of Artificial Blood Cells by Application (2019-2030)
Figure 62. Global Artificial Blood Cells Price (US$/Unit) by Application (2019-2030)
Figure 63. Artificial Blood Cells Value Chain
Figure 64. Artificial Blood Cells Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
